The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

LIX.e

Pneumocystis jiroveci pneumonia

Publications

Neuville M, Borie R, Rodier JM, Debray MP, Danel C, Dombret MC, Aubier M, Crestani B

[Pneumocystis pneumonia in a patient treated with pemetrexed for non small cell lung cancer].

Revue des maladies respiratoires 2011 Jan;28;97-100 — 2011 Jan — 97-100

Velcheti V, Govindan R

Pneumocystis pneumonia in a patient with non-small cell lung cancer (NSCLC) treated with pemetrexed containing regimen.

Lung cancer (Amsterdam, Netherlands) 2007 Aug;57;240-2 — 2007 Aug — 240-2